3rd Circ. Backs Allergan's Win In ERISA Suit Over Drug Prices
A Third Circuit panel refused Friday to revive a proposed ERISA class action accusing Allergan Inc. of taking part in a price-fixing conspiracy that hurt the company's stock value, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article